🇺🇸 FDA
Patent

US 10568844

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 10568844 (RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules) held by The Regents of the University of California expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/14, A61K47/18